title: Cost evaluation of two methods of post tooth extraction hemostasis in patients on anticoagulant therapy.
abstract: The classical management of patients on oral anticoagulant therapy included hospitalisation, cessation of the anticoagulant agent, and extraction of teeth when the prothrombine levels rise. This method was substituted in the High Risk Dental Clinic at Barzilai Medical Center in Ashkelon by use of a tissue sealant (Tisseel) which does not need hospitalisation nor cessation of the anticoagulant therapy. In comparing the last 23 sessions employing the former method to the first 23 sessions using the new method there were significant differences in the cost effectiveness for the health system, provider, insurer and patient. Despite the fact that from the health system point of view the new method is much more cost effective, there is no financial incentive for the provider (hospital) nor awareness on the part of the insurer (General Sick Fund) to embrace it and 'market' it.
authors.affiliation: District Health Office, Ministry of Health, Ashkelon, Israel.
authors.forename: S P
authors.initials: SP
authors.lastname: Zusman
authors.forename: J P
authors.initials: JP
authors.lastname: Lustig
authors.forename: G
authors.initials: G
authors.lastname: Bin Nun
mesh_terms: D000553:Ambulatory Care / Q000191:economics; D000925:Anticoagulants / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017742:Dental Care for Chronically Ill; D005260:Female; D015718:Fibrin Tissue Adhesive / Q000191:economics / Q000627:therapeutic use*; D017048:Health Care Costs; D006488:Hemostasis, Surgical / Q000191:economics* / Q000379:methods*; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007347:Insurance, Dental / Q000191:economics; D007349:Insurance, Health, Reimbursement / Q000191:economics; D007557:Israel; D008297:Male; D014081:Tooth Extraction / Q000191:economics*
chemical_list: D000925:Anticoagulants; D015718:Fibrin Tissue Adhesive